Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Langerin (CD207) is a type II transmembrane protein expressed primarily on Langerhans cells—a dendritic cell subset found in the skin and mucosal tissues. It is part of the C-type lectin receptor family and features a carbohydrate recognition domain that binds high mannose oligosaccharides and other glycans, facilitating the pathogen recognition and uptake necessary for antigen processing and presentation. Langerin’s ability to internalize antigens drives the formation of Birbeck granules, specialized organelles unique to Langerhans cells. Functionally, it acts both as an innate antiviral receptor (notably protecting against HIV-1 by capturing and degrading the virus) and as a mediator of adaptive immunity, presenting processed antigens to T cells. Besides defending against pathogens, Langerin expression is implicated in immune tolerance, tumor immunity, and the regulation of skin inflammation. Gene polymorphisms affecting the ligand binding of Langerin may influence infectious disease susceptibility and immune function. If additional specification is needed (e.g., species or isoform), refer to "CD207" in humans.
Antigen delivery and presentation (candidate vaccines or experimental conjugates targeting Langerin to enhance adaptive immunity); Pathogen uptake/clearance through receptor-mediated endocytosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Langerin (CD207).